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Polychlorinated biphenyls (PCBs) are a large
group of aromatic chlorinated hydrocarbons
that were ﬁrst introduced in the late 1920s and
commercially produced as Aroclor mixtures in
the United States (Battershill 1994; Lind et al.
1999; Safe 1997; Safe and Zacharewski 1997;
Shekhar et al. 1997b; Shipp et al. 1998). These
compounds were used widely in industry for a
wide variety of purposes ranging from plastic
resins to carbonless copy paper. Despite their
utility, PCBs are linked to environmental and
human health risks (Safe 1997; Safe and
Zacharewski 1997; Svendsgaard et al. 1997;
Swanson et al. 1995; Tilson and Kodavanti
1997) that have resulted in the subsequent
banning or highly restricted use of PCBs in
many countries, including the United States.
However, it is estimated that > 1 million tons
of PCBs have been produced, and > 70% of
the PCBs made are still in use (Adami et al.
1995; Ahlborg et al. 1995; Battershill 1994;
Brouwer et al. 1999; Colborn and Smolen
1996; Davidson 1998; Safe 1997). Because of
the high stability of PCBs, they persist in the
environment and have been detected through-
out the food chain (Gladen et al. 1999; Little
et al. 1999; Longnecker et al. 1999; Rogan
et al. 1999). Of direct concern to public health
is the reported accumulation of PCBs in
human tissues, breast milk, and reproductive
organs (Adami et al. 1995; Ahlborg et al.
1995; Baker 2001; Battershill 1994; Eddy
et al. 1996; Fielden et al. 1997; Hany et al.
1999; Nesaretnam et al. 1996; Nicolopoulou-
Stamati and Pitsos 2001; Ogawa et al. 1999;
Safe 1997; Safe and Zacharewski 1997).
The toxic and biochemical effects of com-
mercial PCB mixtures have been extensively
investigated in a variety of laboratory animals
and wildlife species. PCBs have been demon-
strated to alter endocrine, immune, and ner-
vous system functions and cause adverse effects
on reproductive and development of animals,
including humans. After maternal exposure to
PCBs, decreased embryonic growth, delayed
implantation, and increased abortion rates
have been observed (Kholkute et al. 1994;
McNulty 1985; Seiler et al. 1994). PCBs, like
the structurally related DDT (dichloro-
diphenyltrichloroethane) family of pesticides,
appear to have specific effects upon sexual
development and reproductive function in
animals and humans. Although studies on
PCB mixtures have been extensive over the
last several decades, a mechanistic understand-
ing of how PCBs alter reproductive function
and development has been elusive. A con-
founding aspect of PCBs research is the fact
that different animal models give rise to differ-
ent and often conﬂicting outcomes.
PCBs have been proposed to act through a
variety of cellular pathways. Of particular
interest to our studies is the potential estro-
genic activity of these compounds that have
been demonstrated in vitro and in vivo (Arcaro
et al. 1999; Hany et al. 1999; Shekhar et al.
1997a). These studies reveal that the estrogenic
properties of PCBs are weak (Lind et al. 1999),
whereas some PCB mixtures in other systems
exhibit antiestrogenic activity (Ramamoorthy
et al. 1997). However, it is possible that even
weak estrogenic exposure during early develop-
ment may have a profound impact upon post-
natal development. This phenomenon, often
referred to as endocrine disruption, was first
realized with the appearance of uterine and
vaginal/cervical cancers in young women
whose mothers took the synthetic estrogen
diethylstilbestrol (DES) during pregnancy
(Hatch et al. 1998; Kitajewski and Sassoon
2000; Mericskay et al. 2005; Palmer et al.
2002; Saunders 1988). In this case, pathologies
did not appear until 2–3 decades after initial
exposure, leading to the eventual withdrawal of
DES from prenatal care in the 1970s, almost
40 years after initial clinical use (Hatch et al.
1998; Kitajewski and Sassoon 2000; Mericskay
et al. 2005; Palmer et al. 2002; Saunders
1988). DES is a very potent estrogenic com-
pound that contributed to the comparatively
rapid elucidation of the endocrine disruptor
risks posed by its use. By comparison, the
obstacles in identifying weak endocrine dis-
ruptors present in the environment are con-
siderable. It is likely that events that occur
during fetal and/or perinatal life that have a
negative impact on the adult alter normal
embryonic and fetal developmental programs.
Thus, a mechanistic understanding of fetal
endocrine disruption will necessitate an under-
standing of the fundamental mechanisms
underlying normal development of target
organ systems.
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Polychlorinated biphenyls (PCBs) have been proposed to have a weak estrogenic activity and there-
fore pose a risk as potential environmental endocrine disruptors to the perinatal development of the
female reproductive tract. Perinatal exposure to high concentrations of the potent synthetic estro-
gen diethylstilbestrol (DES) induces abnormal development of the female reproductive tract via a
mechanism that acts through the down-regulation of Wnt7a (wingless-type MMTV integration site
family, member 7A). To test the hypothesis that PCBs act as weak estrogens, we injected neonatal
mice with a commercial PCB mixture (Aroclor 1254) or with low levels of DES and measured
effects of exposure on Wnt7a expression and uterine morphology. We report here that neonatal
PCB or low-level DES exposure resulted in the down-regulation of Wnt7a expression. In addition,
both PCB and low-level DES exposure induced changes in the uterine myometrium and gland for-
mation. These data reveal that weak estrogens such as the PCBs act through a Wnt7a-dependent
pathway and suggest that Wnt7a regulation is a sensitive biomarker for testing weak estrogenic can-
didate compounds. The morphologic changes that were elicited by PCBs and DES were different
immediately after exposure, suggesting that Wnt7a-independent pathways are also activated by one
or both of these compounds. Although Wnt7a down-regulation is transient after estrogenic expo-
sure, subsequent morphologic changes became more pronounced during postnatal and adult life,
suggesting that the female reproductive tract is permanently reprogrammed after exposure even to
weak estrogenic compounds. In addition, Wnt7a heterozygous mice were more sensitive to PCB
exposure, revealing an important genetic predisposition to risks of environmental endocrine disrup-
tors. Key words: Aroclor 1254, DES, diethylstilbestrol, endocrine disruptor, female reproductive
tract, PCBs, polychlorinated biphenyls, Wnt7a. Environ Health Perspect 114:898–904 (2006).
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WNT genes direct the proper cytodifferentia-
tion and overall development of the Müllerian-
derived female reproductive tract. Analyses of
two WNT mouse mutants (Wnt7a and Wnt5a;
wingless-type MMTV integration site family,
members 7A and 5A, respectively) have
demonstrated that WNT gene activity is crucial
for proper development and subsequent adult
function (Carta and Sassoon 2004; Mericskay
et al. 2004, 2005; Miller and Sassoon 1998;
Miller et al. 1998a). We have demonstrated
that Wnt7a is down-regulated by DES exposure
during a critical perinatal period of develop-
ment and that this transient down-regulation of
Wnt7a is sufﬁcient to recapitulate the effects of
a complete loss of function of Wnt7a in the
female reproductive tract. DES-exposed wild-
type and Wnt7a mutant mice show aberrant
morphology by 1–2 months after birth and
precancerous and bona fide tumors by
9–18 months after birth (Miller et al. 1998a).
Although these studies provide strong genetic
evidence that Wnt7a is a primary target of DES
exposure, it is important to note that these
studies were performed using very high DES
concentrations [~ 300 µg/g body weight (bw)],
similar to those once used for pregnant women
(Carta and Sassoon 2004; Mericskay et al.
2004; Miller et al. 1998a). Nonetheless, our
data suggest that the negative regulation of
Wnt7a expression is an early and key event that
signiﬁes pathologic risks that appear much later
in life. We thus set out to determine if Wnt7a is
deregulated in response to potential weak estro-
genic compounds such as PCBs, by comparing
the molecular and cellular responses to both
PCBs and very low concentrations of DES
(10 ng/g bw). We demonstrate here that
Aroclor 1254 or low levels of DES are capable
of down-regulating Wnt7a expression in the
neonatal female reproductive tract similar to
that observed after high concentrations of DES.
Unexpectedly, we found that Aroclor 1254 led
to a different phenotypic outcome compared
with DES exposure during early postnatal
development; however, by postnatal day
(PND) 30, DES and Aroclor 1254 exposure
resulted in a similar altered phenotype in the
uterus, including changes in the myometrium
and glandular content. We also found that
mice carrying a homozygous null mutation for
Wnt7a were insensitive to phenotypical changes
caused by either low-level DES exposure or
exposure to Aroclor 1254, consistent with a
central role for Wnt7a in estrogenic endocrine
disruptor events. Wnt7a heterozygous mice
showed an increased sensitivity to Aroclor
1254, demonstrating the potential for genetic
predisposition to endocrine disruption.
Materials and Methods
Chemicals. DES (lot 98H0715; Sigma-Aldrich,
St. Louis, MO) was dissolved in a 10%
ethanol saline solution (0.85% NaCl) at a con-
centration of 0.2 µg/mL. The PCB mixture
Aroclor 1254 (lot 124-191; AccuStandard,
New Haven, CT) was dissolved in a 10%
ethanol saline solution at a concentration of
12.5 mg/mL.
Animals and treatment. Wnt7a hetero-
zygous mice were originally obtained from
B. Parr and A. McMahon (Parr and McMahon
1995, 1998) and maintained on an SV129
background. All animals were maintained in
plastic cages and housed in a temperature-
controlled room (21–22°C) under a 12-hr
light/12 hr dark schedule. All mice used for
this study were generated from heterozygous
crossings. Mice were provided fresh reverse-
osmosis/deionized water and NIH-31 lab chow
(National Institutes of Health, Bethesda, MD)
ad libitum. Pups were injected subcutaneously
with DES (10 ng/g bw/day) or Aroclor 1254
(500 µg/g bw/day) from postnatal day 1
(PND1) to PND5. Controls were similarly
treated with the same volume of vehicle. Mice
were killed by cervical dislocation. All proce-
dures for handling of mice, housing, and main-
tenance were performed according to approved
institutional guidelines that take into account
the humane treatment and all required safe-
guards to minimize suffering.
Tissue processing and cell counts. Tissues
were removed and processed for histology as
previously described (Carta and Sassoon 2004;
Mericskay et al. 2004; Miller, et al. 1998b;
Sassoon and Rosenthal 1993). Brieﬂy, repro-
ductive tracts were dissected in cold phosphate-
buffered saline (PBS) and fixed overnight in
4% PBS-buffered paraformaldehyde. After
dehydration, tissues were embedded in paraf-
ﬁn, sectioned at 6 µm, and stained with hema-
toxylin and eosin (H&E). Comparative
photographs of wild-type and mutant saline-
treated, DES-treated, and Aroclor 1254–
treated mice were taken at the same magniﬁca-
tion. Epithelial cell counts, gland number, and
the thickness of the smooth muscle layer were
obtained from at least three sections per indi-
vidual and at least three individuals per group.
Speciﬁcally, total luminal epithelium cell num-
ber was counted per single whole-uteri cross
section; we counted three sections per individ-
ual and three individuals per group were
counted. Gland number was counted per sin-
gle whole-uteri cross section; three sections per
individual and three individuals per group
were counted. Completely formed glands were
counted as one gland, and invaginating lumi-
nal epithelium in the process of forming glands
was counted as a half gland. We measured the
thickness of smooth muscle from sections that
were stained for smooth muscle actin obtained
from three different uteri cross sections. Three
sections per individual and three individuals
per group were measured. In all cases, sections
were obtained at various rostral–caudal regions
to avoid differences due to the speciﬁc location
within the uterine horn. Statistical evaluation
was made using the unpaired Student t-test.
Statistical significance was assigned at
p < 0.05. All p-values that are significant or
that indicate a trend are shown as either
p < 0.05 or p < 0.01.
In situ hybridization. In situ hybridization
was performed as described previously (Carta
and Sassoon 2004; Mericskay et al. 2004;
Miller, et al. 1998b; Sassoon and Rosenthal
1993). Antisense 35S-labeled riboprobes were
generated for Wnt7a (Miller and Sassoon
1998; Miller et al. 1998a; Sassoon and
Rosenthal 1993). Black-and-white dark-ﬁeld
images were converted to reverse-red grains
and superimposed upon standard light micro-
scope images using Adobe Photoshop (Adobe
Systems Inc., San Jose, CA), allowing for easy
identiﬁcation of labeled structures.
Immunohistochemistry.  Tissue was
processed for paraffin histology as described
above. After sections were deparafﬁnized and
rehydrated, they were blocked for 1 hr in 10%
goat serum, 0.1% Triton X-100, 1% bovine
serum albumin, and 0.2% gelatin. They were
then incubated for 1 hr with a monoclonal
anti-smooth muscle actin at a ﬁnal dilution of
1:50 in blocking buffer. Sections were washed
and incubated in horseradish peroxidase
(HRP)-conjugated anti-mouse IgG secondary
antibodies (Jackson ImmunoResearch
Laboratories, Inc., West Grove, PA) at a ﬁnal
dilution of 1:500 in blocking buffer for 1 hr at
room temperature. Bound mouse antibodies
were detected using streptavidin-HRP (Zymed
Laboratories, San Francisco, CA) with amino-
ethyl carbazole as substrate. 
Quantitative reverse-transcriptase poly-
merase chain reaction (RT-PCR) for Wnt7a.
Total RNA was isolated using TRIzol reagent
(Invitrogen, Carlsbad, CA) according to the
manufacture’s protocol. Concentrations of
the ﬁnal preparations were calculated from an
A260 reading (Beckman DU-7 spectropho-
tometer; Beckman Coulter Inc., Fullerton,
CA, USA) and an aliquot analyzed by gel
electrophoresis to ensure integrity. Reverse
transcriptase generation of cDNA was carried
out in a reaction mix consisting of 1.5 µg ran-
dom primer (Invitrogen), 0.2 mM (d)NTPs
(Omniscript kit; Qiagen, Valencia, CA,
USA), 40 U RNase inhibitor (Omniscript kit,
Qiagen), 4 U Omniscript RT (Omniscript
kit, Qiagen), and 2 µg total RNA in a volume
of 20 µL. Quantitative RT-PCR for Wnt7a
was simultaneously performed on this cDNA
preparation from total RNA from tissues of
three different animals for each treatment
group using the LightCycler-based Sybr
Green I detection system (Roche Molecular
Systems Inc., Branchburg, NJ, USA). Negative
controls without cDNA were used to assess
specificity. A stable housekeeping gene,
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(GAPDH), was used to control for input
RNA. The reactions were prepared for each
cDNA sample as follows: 20 µL reaction con-
sisting of 10 µL Sybr Green optimized buffer
(Qiagen), 20 pmol of each of GAPDH primer
or Wnt7a primer, and 1 µL cDNA. Thermal
cycling conditions were as follows: initial
94°C/15 min, 94°C/15 sec, 55°C/25 sec,
72°C/10 sec, and 40°C/30 sec. The process
was carried out in duplicate for each cDNA
preparation. The amount of transcript was
determined based on the plot of ﬂuorescence
versus cycle number. After adjusting with the
GAPDH control, the differences in cycle cross-
ing points were calculated for each group for a
speciﬁc time point. For a theoretical efﬁciency
of 100%, the fold difference was calculated by
2 to the power of the cycle point difference.
Results are normalized for GAPDH, and data
are shown as mean ± SD from three indepen-
dent experiments run in duplicate.
Results
Aroclor 1254 exposure results in down-regula-
tion of Wnt7a. Perinatal exposure to high lev-
els of DES (200 µg/day) resulted in a
down-regulation of Wnt7a transcripts in the
luminal epithelium of the uterus (Miller et al.
1998a). As a ﬁrst step to assess the estrogenic
effects of Aroclor 1254, we ﬁrst tested whether
low concentrations of DES were capable of
repressing Wnt7a expression because previ-
ous studies suggested that Aroclor 1254 has
only weak estrogenic activity (Brown and
Lamartiniere 1995; Jansen et al. 1993, Shekhar
et al. 1997a). We injected neonatal pups once
a day from PND1 to PND5 with DES at a
dose of 10 ng/g bw, which is similar to levels
used by other laboratories to establish a base-
line for weak estrogens (Newbold et al. 2001)
and is > 500-fold lower than levels used in our
previous studies (Carta and Sassoon 2004;
Mericskay et al. 2004; Miller et al. 1998a).
The effects of DES and Aroclor 1254 upon
Wnt7a gene expression were assessed using
in situ hybridization of uterine tissues from
PND6 mice collected 1 day after the last injec-
tion. Control mice were injected with saline
solution, which was used as a vehicle for both
DES and Aroclor 1254. As expected, Wnt7a
expression was detected throughout the lumi-
nal epithelium in the mouse uterus of saline-
injected mice (Figure 1A). In contrast,
exposure to low levels of DES was sufﬁcient to
down-regulate Wnt7a to levels undetectable
with in situ hybridization (Figure 1B). In
addition, exposure to Aroclor 1254 resulted
in a down-regulation of Wnt7a transcripts
(Figure 1C). Our in situ analyses of DES-
exposed and Aroclor 1254–exposed uteri
showed variable results with occasional low but
detectable levels of signal in the uterine epithe-
lium, suggesting that Aroclor 1254 exposure
and the lower levels of DES used in these
studies may not completely shut down Wnt7a
transcription. To conﬁrm this result, we used
quantitative PCR and observed that Wnt7a
transcripts were reduced by approximately
60% in response to DES or Aroclor 1254
exposure (Figure 1D). These results reveal
that the uterus responds to Aroclor 1254 by
down-regulating Wnt7a, suggesting that
Aroclor 1254 causes effects through mecha-
nisms similar to those affected by DES. Our
quantitative analyses of Wnt7a levels using
RT-PCR revealed a baseline level of Wnt7a
transcripts after DES and/or Aroclor 1254
exposure, whereas in situ hybridization revealed
no detectable levels of Wnt7a transcripts. This
is likely due to both the higher sensitivity of
the RT-PCR approach and the necessity to
normalize our data to GAPDH. However,
the RT-PCR data were obtained from entire
uterine horns in which only a subset of the
cells (luminal epithelium) express Wnt7a.
These data therefore conﬁrm our in situ results
and reveal a similar efficacy of DES and
Aroclor 1254 in down-regulating Wnt7a.
Aroclor 1254 and DES effects are depen-
dent upon Wnt7a genotype: evidence for con-
vergent and divergent pathways. Our results
reveal that both Aroclor 1254 and low-level
DES exposure provoked a down-regulation of
Wnt7a. We had shown previously that loss of
Wnt7a function in mice leads to the same
phenotypic outcome in the uterus as does
perinatal exposure to high levels of DES
(Miller and Sassoon 1998; Miller et al.
1998a). We would therefore predict that
exposure to either Aroclor 1254 or low levels
of DES should result in a similar phenotypic
outcome due to the down-regulation of
Wnt7a. Furthermore, if down-regulation of
Wnt7a is a primary event in response to either
compound, we would predict that Wnt7a
heterozygous mice (Wnt7a +/–) are more sen-
sitive to weak estrogens compared with wild-
type mice (Wnt7a +/+). We therefore
examined uterine horns from wild-type,
Wnt7a +/–, and Wnt7a –/– mice exposed to
either low levels of DES or Aroclor 1254 dur-
ing PND1–PND5. As shown in Figure 2,
control (saline-injected) wild-type and
Wnt7a +/– uterine horns had very similar
morphologies (Figure 2A,D), whereas the
control Wnt7a –/– uterine horns were small
and atrophic in appearance (Figure 2G). By
PND6, the uterine myometrium began to
differentiate in the wild-type and heterozy-
gote uterine horns, whereas no myometrium
can be identiﬁed in the Wnt7a –/– uterus at
this stage (Figure 2G). Exposure to low levels
of DES elicited pronounced folding of the
uterine luminal epithelium as well as a flat-
tened apical appearance to the epithelial cells
in wild-type uteri (Figure 2B). A more pro-
nounced effect was observed in the Wnt7a
+/– uterine epithelium, which became strati-
fied (Figure 2E). This is reminiscent of the
effects we reported in wild-type uteri exposed
to high levels of DES during perinatal
development (Miller et al. 1998a) suggesting
Ma and Sassoon
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Figure 1. Cross sections from wild-type uterine horn
at PND6 after injection of saline (A), DES (B), or
Aroclor 1254 (C) from PND1 to PND5 hybridized with
probe corresponding to Wnt7a. Wnt7a transcripts
were detected throughout the luminal uterine epithe-
lium of saline-treated mice (A). DES or Aroclor 1254
exposure resulted in down-regulation of Wnt7a
expression (B and C, respectively). Photomicro-
graphs are composites of phase and dark ﬁeld (red)
for direct comparison of in situ signal on tissue sec-
tions. Bar = 100 µm. (D) Real-time RT-PCR conﬁrming
that Wnt7a expression was down-regulated 24 hr
after the ﬁnal DES or Aroclor 1254 injection (PND6).
Error bars indicate SD calculated from n ≥ 3 using
the unpaired Student t-test. 
*p < 0.05 compared with saline.
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* *that Wnt7a heterozygote uteri are more sensi-
tive to low levels of estrogenic compounds. In
contrast, Aroclor 1254 exposure did not
induce the same morphologic outcomes as
DES. Significantly less luminal folding was
observed in response to Aroclor 1254 in both
the wild-type and Wnt7a +/– samples; how-
ever, distinct uterine glands formed preco-
ciously (Figure 2C,F). We interpret these
results to suggest that either the precise levels
of estrogenic stimulation are critical for the
morphologic response, or that both DES and
Aroclor 1254 function through Wnt7a-depen-
dent and -independent pathways. For both
DES and Aroclor 1254, Wnt7a was similarly
down-regulated; thus, additional uncharacter-
ized molecular and cellular responses must
exist that are distinct for each compound.
Exposure to low levels of DES or Aroclor 1254
had no obvious effect upon the Wnt7a –/–
uterus, although we noted occasional signs of
water imbibition in some samples as indicated
by increased intercellular spaces (Figure 2H,I).
To precisely measure the morphologic
responses to Aroclor 1254 and low levels of
DES, we used morphometric analyses to
determine the epithelial response (cell num-
ber and gland formation) as well as changes in
the myometrium. As shown in Figure 3, DES
induced an increase in epithelial cell number
in both wild-type and Wnt7a heterozygous
uteri at PND6, although as shown in
Figure 2, the epithelial morphology was dif-
ferent between the two genotypes. In con-
trast, no change in epithelial cell number was
seen between control and Aroclor 1254–
exposed uteri of any genotype (Figure 3A). In
control uteri, a few glands were beginning to
form by PND6 (Figures 2A,3B); however,
exposure to low levels of DES completely
blocked gland formation (Figure 3B), consis-
tent with our previous ﬁndings (Miller et al.
1998a). In contrast, exposure to Aroclor 1254
resulted in a signiﬁcant increase in gland for-
mation in both wild-type and Wnt7a +/–
uteri, and this increase in gland formation
was more pronounced in the Wnt7a heterozy-
gote uteri (Figure 3B). The developing
myometrium can be discerned by the general
morphology of the outer cells of the uterus;
however, to accurately measure myometrial
thickness, we used immunohistochemistry for
smooth muscle actin (Figure 3C). Exposure
to either low levels of DES or Aroclor 1254
resulted in an increase in myometrial thick-
ness, although the effects of DES were more
pronounced compared with Aroclor 1254
(Figure 3D). Neither DES nor Aroclor 1254
had any effect upon the Wnt7a –/– uteri,
which showed no overt myometrial formation
under any conditions. Taken together, these
data reveal that Wnt7a +/– uteri respond dif-
ferently to DES or Aroclor 1254 compared
with Wnt7a wild-type uteri, suggesting an
increased sensitivity in the heterozygote state.
Long-term effects of DES and Aroclor
1254 exposure on uterine morphology. Our
results provide support that Aroclor 1254
exposure results in a down-regulation of
Wnt7a, leading to phenotypic outcomes that
strongly resemble those seen in response to
DES. However, the morphologic effects of low
level DES exposure and Aroclor 1254 were not
identical. Speciﬁcally, both high- and low-level
PCBs and the Wnt7a pathway in the reproductive tract
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Figure 2. Photomicrographs (two magnifications each) of representative H&E-stained cross sections of
wild-type, Wnt7a +/–, and Wnt7a –/– uteri analyzed on PND6, 24 hr after ﬁnal injection of saline, DES, or
Aroclor 1254. Saline-treated wild-type (A) and Wnt7a heterozygous uteri (D) were indistinguishable with
regard to overall size, epithelial morphology, stroma, and myometrial differentiation (arrows). In contrast,
the diameter of the Wnt7a mutant uterus (G) was smaller and the myometrium was not visible (arrows).
Low-level DES exposure resulted in epithelial folding in wild-type uteri (B). In the Wnt7a +/– uteri (E), the
epithelium underwent stratiﬁcation. In contrast to the effects of DES, Aroclor 1254 exposure induced pre-
cocious gland formation (arrows) in both wild-type (C) and Wnt7a +/– uteri (F). In contrast, Wnt7a –/– uteri
showed no consistent or overt changes in morphologies in response to DES (H) or Aroclor 1254 (I) expo-
sure, although we noted signs of water imbibition, as demonstrated by an increase in the intercellular
spaces (arrows). Bar = 100 µm.
Saline DES Aroclor 1254
+/+
+/–
–/–
Figure 3. Uterine responses at PND6 to saline, DES, or and Aroclor 1254 exposure in wild-type, Wnt7a
heterozygous, and mutant uteri involving changes in epithelial cell number (A), gland formation (B), and
myometrial thickness (C,D). (A) Histogram showing changes in epithelial cell number. (B) Histogram show-
ing changes in gland counts. DES exposure results in a complete block in gland formation in both Wnt7a
wild-type and heterozygous uteri; in contrast, Aroclor 1254 exposure results in a significant increase in
glandularity in wild-type and heterozygous uteri. In Wnt7a mutant uteri, no glands are formed under any
conditions. (C) Immunohistochemistry for anti-smooth muscle actin revealing myometrial thickness in uter-
ine samples. Both DES-exposed and Aroclor 1254–exposed uteri showed moderate to marked increases in
myometrial thickness compared with saline-exposed controls. Bar = 100 µm. (D) Histogram showing
changes in myometrial thickness measured from cross sections as shown in (C). Both low-level DES and
Aroclor 1254 exposure resulted in an increase in myometrial thickness in both wild-type and heterozygous
uteri, whereas the myometrium is undetectable in Wnt7a mutant uteri at this stage.
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D p < 0.05DES exposure blocked gland formation and
had a more pronounced effect upon the
myometrium and epithelial cell number at
PND6 (Figures 2 and 3). Because gland for-
mation and myometrial development initiate
at the early postnatal stage we examined, we
repeated our studies but examined uterine tis-
sue on PND30, corresponding to a stage when
cytodifferentiation is complete but tissues have
not been subjected to high levels of endoge-
nous circulating estrogens (Carta and Sassoon
2004). As shown in Figure 4, Aroclor 1254–
exposed wild-type and Wnt7a +/– uteri that
had increased numbers of uterine glands at
PND6 show a striking decrease in gland num-
ber at PND30, mirroring the phenotype
observed in the DES-exposed uteri. As previ-
ously reported, Wnt7a –/– uteri do not form
uterine glands (Miller and Sassoon 1998;
Miller et al. 1998a), and exposure to either
DES or Aroclor 1254 does not change this
phenotypic outcome. Exposure to DES or
Aroclor 1254 increased myometrial thickness
at PND30 in both Wnt7a wild-type (+/+) and
+/– mice compared with saline controls
(Figure 4). In the Wnt7a –/– mice, exposure
to saline had no effect, and the myometrial
layers were significantly larger, as previously
reported (Carta and Sassoon 1994; Miller and
Sassoon 1998). Surprisingly, although both
DES and Aroclor 1254 had a pro-myogenic
effect on Wnt7a +/+ and +/– uteri at PND30
compared with saline controls, Wnt7a –/–
uteri exposed to either compound showed a
decrease in the thickness of the myometrial
layer compared with saline-exposed Wnt7a
–/– uteri (Figure 4). The myometrial thick-
ness of DES-exposed or Aroclor 1254–
exposed Wnt7a –/– uteri, however, was similar
to that of uteri from wild-type and hetero-
zygote uteri similarly exposed at PND30
(Figure 4).
Discussion
PCBs can act as endocrine-disrupting agents
that presumably exert deleterious effects on
the gonads and the reproductive tract
because of their estrogenic and/or anti-
estrogenic activity (Kholkute et al. 1994).
The reproductive tracts in both males and
females are particularly sensitive to hor-
monal disruption during perinatal develop-
ment (Miller et al. 2004; Yang et al. 2005).
Furthermore, reproductive tissues remain
sensitive to circulating estrogenic com-
pounds, which may pose an increased risk of
reproductive tract cancers during adult life
(Hatch et al. 2000; Shekhar et al. 1997a).
Despite several decades of studies focused
upon the developmental impact of PCB expo-
sure upon the female reproductive tract, the
molecular and cellular pathways that lead to
reproductive tract malformations, dysfunc-
tions, and cancer progression after PCB
exposure are poorly understood. In contrast
to the situation with PCBs and other “weak”
estrogenic compounds, a strong mechanistic
and epidemiologic link exists between expo-
sure to the synthetic estrogen DES during
perinatal development and malformations of
the uterus and the subsequent appearance of
cancers in the adult (Sassoon 1999). Work
from our laboratory has previously implicated
the WNT gene pathway as a critical target
that is disrupted by perinatal DES exposure
in the female reproductive tract (Carta and
Sassoon 2004; Kitajewski and Sassoon 2000;
Miller and Sassoon 1998; Miller et al. 1998a).
WNT genes direct the proper cyto-
differentiation and overall development of the
murine female reproductive tract, which is
relatively undifferentiated at birth and is sub-
ject to speciﬁc epithelial–mesenchymal inter-
actions and to regulation by sex-steroid
hormones during development and adult life.
Postnatal reproductive tract development pro-
ceeds in the absence of high levels of endoge-
nous circulating estrogens and is disrupted by
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Figure 4. Changes in uterine myometrial thickness and glands in wild-type and Wnt7a mutant mice on PD30
after exposure to DES and Aroclor 1254 on PD1–PD5. DES and Aroclor 1254 exposure resulted in increased
uterine myometrial thickness and a decrease in glands in wild-type mice (A–F), whereas the Wnt7a mutant
mice (G–L) showed an increase in myometrial thickness (line, D–F, J–L) that occurred in the absence of
exogenous treatment with DES or Aroclor 1254. The increase in myometrial thickness was blocked by DES or
Aroclor 1254 exposure in the Wnt7a mutant. H&E-stained cross sections and immunohistochemistry for anti-
smooth muscle actin are shown for wild-type (+/+; A–C and D–F) and Wnt7a mutant (–/–; G–I and J–L) uteri,
respectively; bar = 100 µm. (M) Histogram depicting gland number obtained from cross sections similar to
those shown in (A–L). (N) Myometrial thickness measured from cross sections similar to those shown in (A–L). 
*p < 0.05, **p < 0.01, #p < 0.005, and ##p < 0.001 compared with saline. 
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Aroclor 1254exposure to estrogenic chemicals during this
period. By employing mouse genetic models,
we and other groups have demonstrated that
Wnt7a is a central target gene in the DES
response after perinatal exposure and that the
deregulation of Wnt7a is dependent upon the
presence of the estrogen receptor α-isoform
(Couse and Korach 2004; Miller et al. 1998a;
Sassoon 1999). Thus, Wnt7a down-regulation
is a key response to estrogen in the uterus.
The central role of Wnt7a is underscored by
the observation that perinatal DES exposure
down-regulates Wnt7a, leading to a female
reproductive tract phenotype that closely
resembles that observed in Wnt7a nullizygous
mice (Miller et al. 1998a; Sassoon 1999).
Additionally, exposure of Wnt7a mutant uteri
to estrogens fails to elicit a uterotrophic
response (Carta and Sassoon 2004). Because
Wnt7a down-regulation is an immediate
molecular response to estrogen via estrogen-
receptor–dependent pathways, we tested
whether Wnt7a down-regulation could be
used as a bioassay to better address the
mechanism of action of suspected weak estro-
genic compounds or mixtures such as PCBs.
In this study, we demonstrated that Aroclor
1254 (PCBs commercial mixture) exposure
results in a down-regulation of Wnt7a.
Our previous studies were performed
using high doses of DES, reflecting those
administered to pregnant women; however,
for this study we chose to compare PCB
exposure with low-level DES exposure to
ascertain if lower levels of DES result in
Wnt7a down-regulation. We found that
Aroclor 1254 and low-level DES exposure
resulted in down-regulation of Wnt7a and in
the subsequent induction of overlapping
phenotypic malformations in the uterus,
including reduced gland formation and an
increase in thickness of the smooth muscle
layer, by PND30 compared with saline-treated
mice. Finally, we found that neither DES nor
Aroclor 1254 exposure altered the morphology
of uteri from Wnt7a mutant mice, although we
observed that these mice already displayed
reduced gland formation and a disorganized
myometrium due to the absence of Wnt7a
expression, as previously reported (Miller and
Sassoon 1998; Miller et al. 1998a; Sassoon
1999). Taken together, our data demonstrate
that Aroclor 1254 and low-level DES exposure
affect the perinatal uterus via the Wnt7a signal-
ing pathway. The effects of low-level DES
exposure and Aroclor 1254 exposure were
more pronounced in Wnt7a +/– reproductive
tracts, including pronounced luminal epithe-
lium stratiﬁcation. These observations conﬁrm
that deregulation of the Wnt7a pathway is a
central response to PCB exposure in the devel-
oping reproductive tract. In addition, the
observed increase in sensitivity of the Wnt7a
heterozygous reproductive tract supports the
model that genetic predisposition plays a key
role in the response to environmental endo-
crine disruptors. Given that WNT signaling
involves a large variety of gene products, there
is likely to be a complex genetic background
effect in human populations in response to
environmental endocrine disruptors.
Assessment of the potential dangers and
estrogenic risks of environmental contami-
nants has heavily relied on rodent models in
which neonatal mice are exposed and then
end points are measured, including the
uterotrophic response and morphologic
abnormalities within the reproductive tract
(Gray et al. 2004; Spearow and Barkley
2001). These studies involve time-consuming
histologic analyses and large numbers of ani-
mals. As demonstrated in our studies, the
morphologic effects of PCBs are not as severe
as those seen in response to strong estrogenic
stimuli, such as high or moderate levels of
DES, and are therefore difﬁcult to assess. The
studies presented here demonstrate that a
rapid and simple analysis of Wnt7a message
levels in the reproductive tract after chemical
exposure could be a reliable bioassay to mea-
sure potential endocrine disruptors. The
down-regulation of Wnt7a expression in the
uterine luminal epithelium was observed in
response to both Aroclor 1254 and DES
exposure; however, the initial morphologic
responses seen at PND6 were different.
Specifically, DES exposure induced signifi-
cant epithelium stratification, whereas we
found no major changes in the luminal
epithelium in PCB-exposed uteri, with the
notable exception that there is a significant
increase in uterine gland number in both
wild-type and Wnt7a heterozygous mice. The
induction of speciﬁc outcomes of PCBs, such
as a transient increase in gladularity, may
reﬂect the fact that the PCB mixture used in
this study, namely, Aroclor 1254, is a com-
plex mixture of > 40 congeners that may
induce a variety of effects that are not evoked
by estrogen. These observations suggest that
PCB exposure activates both Wnt7a-depen-
dent and -independent signaling pathways.
However, the observation that neonatal expo-
sure to both Aroclor 1254 and DES results in
a similar phenotype by PND30 suggests that
the transient down-regulation of Wnt7a trig-
gers a permanent reprogramming of the
developing reproductive tract. Work by us
and others indicates that this reprogramming
culminates in the development of highly
abnormal tissue with spontaneous neoplasias
of variable frequencies. The future assessment
of endocrine disruptors and their potential
risks will depend upon a thorough mechanis-
tic understanding of the molecular and cellu-
lar processes that result from the deregulation
of normal cell signaling events guiding repro-
ductive tract development.
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